20/20 GeneSystems‘ patent, #6,770,485 was issued today by the US Patent and Trademark office. Entitled ‘Rapid assay, method and system for detecting biowarfare agents’, the patent covers technology used in the BioCheck Powder Screening Test Kit.
Screen for multiple bioterror agents and rule out most false alarms
Introducing OneTestA new blood test for multiple cancers which can help identify the disease at an early, more treatable stage.
Sorry, comments are closed for this post.